Bulletin du Cancer
Volume 93, issue 1, Janvier 2006
Volume 93, issue 1, Janvier 2006
Éditorial
Bientôt centenaire
(p.3-4)
Philippe Jeanteur, Paul Cappelaere
Brève
Cancer prostatique : un automne explosif
(p.5-6)
Jean Bénard
Open Access
Synthèse
The frequency of cancer in France in year 2002, and trends since 1968
(p.7-11)
Catherine Hill, Françoise Doyon
EGFR-targeted therapies: what’s new?
(p.13-8)
Stéphane Vignot, Benjamin Besse, Jean-Charles Soria, Gérard Milano, Jean-Philippe Spano
PI3K-AKT-mTOR pathway inhibitors
(p.19-26)
Alexis Cortot, Jean-Pierre Armand, Jean-Charles Soria
Histone-deacetylases inhibitors: from TSA to SAHA
(p.27-36)
Paul Peixoto, Amélie Lansiaux
Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives
(p.37-42)
Jean-Philippe Spano, Guislaine Carcelain, Christine Katlama, Dominique Costagliola
What is new in the surgical treatment of pelvic gynecologic cancers?
(p.43-9)
Fabrice Narducci, Frédéric Sabban, Édith Vanlerenberghe, Anne Lesoin, Annick Chevalier, Hélène Gauthier, Sophie Taieb, Bernard Castelain, Éric Leblanc
Current trends in head and neck squamous cell carcinomas
(p.51-9)
Jean Lacau Saint-Guily, Sophie Périé
Recent advances in digestive oncology (pancreas excluded)
(p.61-5)
Dominique Elias
Pancreatic cancer: what is new in 2005?
(p.67-72)
Pascal Hammel
Update on cerebral tumors
(p.73-81)
Alexandra Benouaich-Amiel, Jean-Yves Delattre
News of the year 2005 in sarcomas
(p.83-9)
Jérôme Fayette, Pierre Méeus, Marie-Pierre Sunyach, Philippe Thiesse, Isabelle Ray Coquard, Jean-Yves Blay
New entities in pathological classification and new therapeutic options in renal cell carcinoma
(p.91-100)
Jacques-Olivier Bay, Frédérique Penault-Llorca, Alain Ravaud, Christine Chevreau, Sylvie Négrier, Bernard Escudier
Treatment of multiple myeloma
(p.101-6)
L Terriou, X Leleu, I Yakoub-Agha
Monoclonal antibodies for lymphomas and leukemias in 2005
(p.107-18)
Régis Peffault de Latour, Marie Robin, Jacques Olivier Bay
What’s new in geriatric oncology ?
(p.119-23)
Catherine Terret, Gilles Albrand, Martine Jeanton, Philippe Courpron, Jean-Pierre Droz
What is new in brachytherapy ?
(p.125-32)
Didier Peiffert
Refusing treatment: patient responsability and autonomy
(p.133-7)
Daniel Oppenheim, Sarah Dauchy, Olivier Hartmann
Electronic journal of oncology
Epirubicin-docetaxel in advanced gastric cancer: two phase II studies as second and first line treatment
(p.10001-6)
Suzanne Nguyen, Christine Rebischung, Johan Van Ongeval, Michel Flesch, Mustapha Bennamoun, Thierry André, Marc Ychou, Erik Gamelin, Elisabeth Carola, Christophe Louvet